Cargando…

Increased serum 1,25-dihydroxyvitamin D levels in gynecologic cancer patients with Post-Acute-Covid-Sequela (PASC)/Long COVID

Post-acute sequelae of COVID-19 (PASC), also known as Long-Covid (LC), may affect 10–30 % of COVID-infected patients, and is characterized by a variety of debilitating symptoms lasting over 3 months after the acute infection, including but not limited to dyspnea, fatigue, and musculoskeletal, cognit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellone, Stefania, Siegel, Eric E., Santin, Alessandro D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654147/ https://www.ncbi.nlm.nih.gov/pubmed/38029227 http://dx.doi.org/10.1016/j.gore.2023.101301

Ejemplares similares

Sleep Disturbance Severity and Correlates in Post-acute Sequelae of COVID-19 (PASC)
por: Pena-Orbea, Cinthya, et al.
Publicado: (2023)

Serum 1,25-Dihydroxyvitamin D: An Outcome Prognosticator in Human Sepsis
por: Nguyen, H. Bryant, et al.
Publicado: (2013)

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
por: Pretorius, Etheresia, et al.
Publicado: (2021)

Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC)
por: Ong, Ian Z., et al.
Publicado: (2023)

Editorial: Post-Acute Sequelae of COVID-19 infection (PASC): Implications for geriatric and neurological care
por: Ng, Ted Kheng Siang, et al.
Publicado: (2023)

Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management
por: Munipalli, Bala, et al.
Publicado: (2022)

Post-Acute Sequelae of COVID-19 (PASC) in Pediatrics: Factors That Impact Symptom Severity and Referral to Treatment
por: Soprano, Catherine M., et al.
Publicado: (2023)

The pathophysiology of postacute sequelae of COVID-19 (PASC): Possible role for persistent inflammation
por: Marshall, Gailen D.
Publicado: (2023)

Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC)
por: Guntur, Vamsi P., et al.
Publicado: (2022)

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
por: Proal, Amy D., et al.
Publicado: (2021)

Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC)
por: Patterson, Bruce K., et al.
Publicado: (2023)

SAT-356 Reversible Suppression of Serum 1,25-Dihydroxyvitamin D in Williams Syndrome
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

OBJECTIVE CARDIOVASCULAR AUTONOMIC ABNORMALITIES IN POST-ACUTE SEQUELAE OF COVID-19 (PASC): OVERALL AND SEX-BASED PREVALENCE
por: Hira, R., et al.
Publicado: (2022)

Repurposing exercise training and pharmacological therapies to address the post-acute sequelae of COVID-19 (PASC) in diabetes mellitus
por: Jie Chee, Ying, et al.
Publicado: (2023)

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Sherif, Zaki A, et al.
Publicado: (2023)

THU233 Reduction Of Overutilization Of 1,25-Dihydroxyvitamin D
por: Brown, Jeremy, et al.
Publicado: (2023)

Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome
por: Bierle, Dennis M., et al.
Publicado: (2021)

(PO-071) A Group Psychotherapy for Patients with Post-Acute Sequelae of COVID-19 (PASC) Experiencing Psychological Stress
por: Padda, Karanbir, et al.
Publicado: (2022)

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Mohandas, Sindhu, et al.
Publicado: (2023)

Unraveling pathophysiologic mechanisms contributing to symptoms in patients with post‐acute sequelae of COVID‐19 (PASC): A retrospective study
por: Dierckx, Wendel, et al.
Publicado: (2023)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
por: Pretorius, Etheresia, et al.
Publicado: (2022)

Autonomic Nerve Involvement in Post-Acute Sequelae of SARS-CoV-2 Syndrome (PASC)
por: Chung, Tae Hwan, et al.
Publicado: (2022)

Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System
por: Faye, Pierre Antoine, et al.
Publicado: (2019)

Gender-Dependent Characteristics of Serum 1,25-Dihydroxyvitamin D/25-Hydroxyvitamin D Ratio for the Assessment of Bone Metabolism
por: Fujita-Yamashita, Manami, et al.
Publicado: (2021)

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014)

The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study
por: Wynberg, Elke, et al.
Publicado: (2022)

417. Impact of Post-acute Sequelae of COVID-19 (PASC) on Healthcare Workers (HCW) in NYC Public Hospital in the South Bronx
por: Lim, Chee Yao, et al.
Publicado: (2023)

Significance of 1,25-Dihydroxyvitamin D(3) on Overall Mortality in Peritoneal Dialysis Patients with COVID-19
por: Baralić, Marko, et al.
Publicado: (2023)

Intramammary 25-hydroxyvitamin D(3) and 1,25-dihydroxyvitamin D(3) treatments differentially increase serum calcium and milk cell gene expression
por: Wells, T.L., et al.
Publicado: (2022)

Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC)
por: Santana, Kelly, et al.
Publicado: (2023)

Serum 1,25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Diseases
por: Chung, Sungjin, et al.
Publicado: (2017)

Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3
por: Halicka, H. Dorota, et al.
Publicado: (2012)

The relationship of 1,25-dihydroxyvitamin D and Vitamin D binding protein in periodontitis
por: Rafique, Sara, et al.
Publicado: (2019)

Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis
por: Li, Chih-Huang, et al.
Publicado: (2019)

Editorial: Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). Updated Terminology for the Long-Term Effects of COVID-19
por: Parums, Dinah V.
Publicado: (2023)

Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [(11)C]PBR28 PET correlates with vascular disease measures
por: VanElzakker, Michael B., et al.
Publicado: (2023)

tDCS as telehealth intervention to reach patients with Post-Acute Sequelae of SARS-CoV-2 (PASC)
por: Charvet, Leigh, et al.
Publicado: (2023)

8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D(3)-induced growth inhibition without affecting 1,25-dihydroxyvitamin D(3)-stimulated differentiation of primary mouse epidermal keratinocytes
por: Bollag, Wendy B, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_9jcb0q3vnioqnmnl7c97supv80